|
|
||||||||
Biology of Reproduction, Vol 15, 168-172, Copyright © 1976 by Society for the Study of Reproduction
1 Department of Physiology, University of Manitoba,
770 Bannatyne Avenue
Winnipeg, Manitoba Possible changes in response of the hypothalamo-pituitary prolactin (PRL) axis to long acting
(fluphenazine enanthate; FPZ) and short acting (chlorpromazine; CPZ) phenothiazine derivatives
were investigated in male and female rats at different stages of maturation. Maximal serum PRL
concentrations after CPZ were not different in male rats aged 20, 40 or 60 days (130 ng/ml).
Serum PRL levels were elevated for 3 h in the prepubertal and pubertal males and for 4 h in adult
rats. The decline of PRL was most rapid in the youngest rats, and slowest in the 60 day old males.
In females, maximal serum PRL concentrations after CPZ were 2 to 3 times higher in 40 and 60
day old rats than in 20 day old animals (100 ng/ml). The decline in serum PRL in female rats again
was most rapid in younger rats. The elevation of PRL lasted as long as 4 h in all age groups. Ten
days after FPZ serum PRL was not increased in prepubertal rats, but still was twice as high in peripubertal and adult animals as compared to control values in both sexes prior to treatment. These
studies indicate significant age and sex differences in PRL response after phenothiazines and these
variations must be taken into account when using this drug to maintain elevated serum prolactin
levels.
Note:
ACKNOWLEDGMENTS
The studies were supported by research grants
from the Medical Research Council of Canada and the
USPHS Child Health and Human Development Institute No. HD 07843-03. We thank the NIH for supply
of the radioimmunoassay kits for rPRL. We are indebted to Mr. Jeffry Harris for the preparation of
the figures and to Mrs. C. Froese for typing the
manuscript.
This article has been cited by other articles:
![]() |
P. M. Schyve, F. Smithline, and H. Y. Meltzer Neuroleptic-induced Prolactin Level Elevation and Breast Cancer: An Emerging Clinical Issue Arch Gen Psychiatry, November 1, 1978; 35(11): 1291 - 1301. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |